BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/27/2025 7:06:36 AM | Browse: 2 | Download: 0
 |
Received |
|
2025-01-12 09:41 |
|
Peer-Review Started |
|
2025-01-12 09:41 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-02-19 02:11 |
|
Revised |
|
2025-03-05 02:07 |
|
Second Decision |
|
2025-03-26 02:39 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-03-26 08:51 |
|
Articles in Press |
|
2025-03-26 08:51 |
|
Publication Fee Transferred |
|
2025-03-09 13:21 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-04-16 10:31 |
|
Publish the Manuscript Online |
|
2025-04-27 07:06 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Application of circulating tumor DNA liquid biopsy in nasopharyngeal carcinoma: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xin-Yao Zhou, Yuan-Jun Jiang, Xiao-Ming Guo, Dong-Hui Han, Yao Liu and Qiao Qiao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Beijing Bethune Charitable Foundation and Provincial Natural Science Foundation of Liaoning |
2022-MS-190 |
|
| Corresponding Author |
Qiao Qiao, Associate Professor, Chief Physician, PhD, Department of Radiation Oncology, The First Affiliated Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang 110000, Liaoning Province, China. braveheart8063@outlook.com |
| Key Words |
Nasopharyngeal cancer; Radiation therapy; Circulating tumor DNA; Epstein–Barr virus; Minor residual disease; Guide treatment; Predicting prognosis; Case report |
| Core Tip |
The results of circulating tumor DNA (ctDNA)-based minimal residual disease testing have been used as a biomarker for some solid tumors, but their use as a biomarker to guide the treatment and predict the prognosis of nasopharyngeal carcinoma (NPC) has not yet been reported. We report a patient who tested positive for ctDNA and negative for Epstein‒Barr virus DNA. During the follow-up period, ctDNA signals became positive before tumor progression and became negative again at the end of treatment. This study represents a breakthrough in the use of biomarkers to assess the prognosis of NPC. |
| Publish Date |
2025-04-27 07:06 |
| Citation |
<p>Zhou XY, Jiang YJ, Guo XM, Han DH, Liu Y, Qiao Q. Application of circulating tumor DNA liquid biopsy in nasopharyngeal carcinoma: A case report and review of literature. <i>World J Clin Cases</i> 2025; 13(21): 105066</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i21/105066.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i21.105066 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
